Breakthrough Therapies: Market Dynamics and Investment

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
Breakthrough Therapies: Market Dynamics and Investment Opportunities Report 2017

Dublin, March 07, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Breakthrough Therapies: Market Dynamics and Investment Opportunities" report to their offering. This report highlights the challenges and opportunities of developing breakthrough therapies, it compares and contrasts difference fast track drug development approaches (logistics, criteria, and implications) and the potential risk and rewards of gaining BTD.

It analyzes BTD in different therapy areas (cardiovascular, central nervous systems and neurology, rare diseases, oncology and other diseases), leading companies, approved and pipeline products, pricing market access and product revenues.

It reviews BTD successes and failures and discusses the different business strategies that companies have adopted in order to maximize the competitive advantage of BTD. It summarizes the current regulatory framework and the potential application of BTD in other regions of the world, and the potential to combine BTD with early access to medicine schemes to improve patient access to medicine to treat rare diseases and address areas of high unmet clinical need.

Report Includes - An overview of the global markets for breakthrough therapies, their dynamics, and investment opportunities - Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2022 - A look at the materials used in the industry ranging from inorganic clays and concrete to iron and steel, and to commodity and specialty polymers - The challenges and opportunities of developing breakthrough therapies - A compare and contrast of different fast track drug development approaches (logistics, criteria and implications) and the potential risk and rewards of gaining break through designation - Analysis of the regulatory environment - Profiles of major players in the industry

Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing The Report - Scope Of Report - Intended Audience - Methodology And Information Sources 2: Summary 3: Overview - Defining Breakthrough Therapy Designation 4: Commercial Application Of Breakthrough Therapy Designation - Introduction - Cardiovascular - Central Nervous System And Neurological Disorders - Infectious Diseases - Oncology - Rare Diseases - Other Diseases 5: Implications Of Breakthrough Therapy Designation On Business Strategy - Introduction 6: Regulatory Implications And Breakthrough Therapy Designation - Expedited Programs - Significance Of Btd For The Pharmaceutical And Biotechnology Industries 7: Company Profiles - Abbvie Inc. - Acadia Pharmaceuticals Inc. - Adaptimmune Therapeutics Plc - Aduro Biotech Inc. - Aimmune Therapeutics Inc. - Alexion Pharmaceuticals Inc. - Allergan Plc - Amgen Inc. - Anatara Lifesciences Limited - Ariad Pharmaceuticals Inc. - Astrazeneca Plc - Avexis Inc. - Boehringer Ingelheim Gmbh - Celldex Therapeutics Inc. - Clovis Oncology Inc. - Daiichi Sankyo Company, Limited - DBV Technologies - Eisai Co. Ltd. - Eli Lilly And Company - Exelixis Inc. - F. Hoffmann-La Roche Ltd. - Gilead Sciences Inc. - Glaxosmithkline Plc - Immunomedics Inc. - Individor Plc - Jazz Pharmaceuticals - Johnson & Johnson - Juno Therapeutics Inc. - Kite Pharma Inc. - Merck & Co. Inc. - Merck Kgaa - Novartis AG - Pfizer Inc. - Pharmacyclics Inc. - Progenics Pharmaceuticals Inc. - Regeneron Pharmaceuticals Inc. - Rhythm Pharmaceuticals Inc. - Syndax Pharmaceuticals Inc. - Syneurx International Corporation - Teva Pharmaceuticals Inc. - Trevena Inc. - Vertex Pharmaceuticals Inc. - Vtesse Inc. - Wellstat Therapeutics Corporation 8: References 9: Acronyms 10: Endnotes For more information about this report visit http://www.researchandmarkets.com/research/ps...eakthrough

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Pharmaceuticals

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 138

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
JobPlanner Advances Mobile Tech for Construction Crews

Updated Category News Views 101

JobPlanner's Attempt to Tackle a Labor Crunch Construction's been walking on the tightrope for a while now. With a workforce that's graying like a couple of old Neanderthals and fewer fresh faces showing up on site, contractors are sweating bullets. Today, in the thickets of Austin's business landscape, JobPlanner rolled out an expanded Mobile Field Management toolkit,...

Continue Reading
EZ MOUSE Revolutionizes Multi-Device Computing Control

Updated Category News Views 74

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Continue Reading
LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 23

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
OpenAssets Sets Up Shop in Abu Dhabi, Joins Hub71

Updated Category News Views 49

OpenAssets Carves a Niche in Abu Dhabi OpenAssets has just staked a claim in the Middle East by setting up its headquarters in the Abu Dhabi Global Market (ADGM). Picture this: a digital asset infrastructure provider unfurling its wings in one of the most dynamic economic landscapes—it's like watching a rookie clinch the game at the stock pit. But there's more, folks....

Continue Reading
Lauri Thompson Joins UWSN Board: A New Era Begins

Updated Category News Views 56

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....

Continue Reading
Fort Riley and Fort Wainwright Get Wi-Fi Boost

Updated Category News Views 136

Reliable Connectivity for Soldiers: A Strategic Move Wi-Fi probably wouldn't be on top of the list in a battlefield strategy session, but give it a thought—it’s the digital lifeline for our troops off-duty. That’s what’s cooking with the U.S. Army’s big move to amp up reliable Wi-Fi at Fort Riley and Fort Wainwright, thanks to Boldyn Networks and their BaseNet...

Continue Reading
Poetry Collection Illuminates Life's Big Moments

Updated Category News Views 59

A Journey Spanning Four Decades A poetry collection tracing personal and emotional epiphanies—now there's something more gripping than any stock ticker. Kelly Michelle Long's 'Finding Yourself Once Again' packages four decades of pen to paper in a book that’s a tapestry of heartfelt stories and reflections. It's personal but relatable, casting a light on those intense...

Continue Reading
Specialty1 Partners: Top Workplaces Triumph in 2026

Updated Category News Views 82

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...

Continue Reading
Wison's Flex-to-X: Shaping Future of Green Energy

Updated Category News Views 22

Cracking the Code: Wison's Flex-to-X Debut You'll never catch me tossing into new tech fads blindly, but Wison Engineering's launch of Flex-to-X during ADIPEC 2026 has truly piqued my interest. We're talking about a serious move for green fuels and chemicals, using their chops in modular execution as a springboard into something bigger. From Engineer-to-Order to...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Package Protection Solution for Home Safety

Updated Category News Views 147

Innovative Package Protection Solution In an age where delivered items can often fall prey to theft or damage, a new invention seeks to combat these challenges. The inventor, motivated by a need for effective protection against porch theft, has introduced a product known as the P P S. This innovative design focuses on keeping important deliveries secure and shielded from...

Continue Reading
DeFinity Markets Upgrades Security with Chainalysis Integration

Updated Category News Views 331

DeFinity Markets Transforms Digital Asset Security DeFinity Markets®, a pioneering full-stack platform for institutional digital asset matching and settlement, has taken an impressive step forward by integrating Chainalysis, a renowned blockchain data platform. This momentous collaboration is set to elevate DeFinity's risk management and compliance practices. The Role of...

Continue Reading
Actuate Therapeutics' Innovative Trial Combines Elraglusib in Cancer Treatment

Updated Category News Views 183

Exciting New Collaboration in Cancer Research Actuate Therapeutics, Inc. (NASDAQ: ACTU) has announced a groundbreaking initiative in the fight against advanced pancreatic cancer. This esteemed biopharmaceutical company is embarking on a Phase 1b clinical trial that combines elraglusib, a novel GSK-3? inhibitor, with Incyte's PD-1 inhibitor, retifanlimab, and the...

Continue Reading
Waymo Co-founder Shares Insights on Tesla's Data Dominance

Updated Category News Views 139

Tesla Inc. (NASDAQ: TSLA) stood out in the autonomous vehicle game back when discussions heated up about who was leading the pack. Waymo’s co-founder, Anthony Levandowski, wasn’t shy about saying Tesla had a major leg up thanks to its treasure trove of data from millions of electric vehicles on the road. That’s no small potatoes—more cars mean more real-world...

Continue Reading
Revolutionizing AI: Quantinuum's New Quantum Technology Unveiled

Updated Category News Views 473

Transformative Breakthrough in Quantum AI Technology Quantinuum Unveils Generative Quantum AI Framework that Harnesses Unique Quantum-Generated Data to Tackle Complex Problems Impossible for Classical Computing Quantinuum has recently announced a significant breakthrough in the realm of artificial intelligence through its innovative Generative Quantum AI (Gen QAI)...

Continue Reading